News About: Pharm. Industry
Dongkwang to prepare revival chance after composition settlement.Dongkwang made a final settlement of the composition on April 17 by taking almost 7 years from when the composition started in Sept. 1999. Now, the company has made a successful...
|
Hanmi to register a protein related drug patent.
Hanmi announced that a patent registration for the polypeptide combined substance having a sustained physiological activity had been completed.
The patent illustrated a novel technology revealing that a significan...
Daehwa to patent a direct injectable form of pacliataxel.
Daehwa pharmaceutical company announced on April 19 that the company completed a patent registration for a direct injectable form of pacliataxel into the bladder tumor sites, which is the first in such treatment for b...
Shinshin Pharm. to certify ISO9001 and 13485.
Shinshin pharmaceutical company has obtained the ISO13485 and ISO9001 certifications from DNV (Det Norske Veritas), a world reputed quality examination agency, on the date of April 12
ISO9001 applies to overall in...
KPMA exerting to extend tax privilege due for drug R&D.
The Korea Pharmaceutical Manufacturers Association (KPMA) is working hard to extend the due period of tax exemption for the drug R&D expenditures, which will expire at the end of this year according to a special tax p...
Pfizer Korea plant to close its operation.
A lot of foreign multinational drug corporations in Korea have closed their production plants including Pfizer Korea's Seoul plant.
Through twice M&A of Warner Lambert in 2000 and Pharmacia in 2003, Pfizer had met...
Merck successful symposium on NiaspanorDuring the 5th Asia Pacific Society of Arteriosclerosis and Vascular Diseases (APSAVD) in Jeju island, Merck Korea took a symposium titled "Therapeutic Innovation in Atherogenic...
|
Stiefel Korea to commit 20% sales growth this year.Stiefel Korea, a skin care specialized company, took a strategic seminar after the new 2006 fiscal year business inauguration ceremony, declaring 20% growth target to solidify a...
|
LG to exchange Letter of Intent with Sinovac for bird flu vaccine.
LG Life Science agreed with Sinovac of China, a vaccine company, for a joint development of AI vaccine (avian flu vaccine) under the Letter of Intent on April 17.
Sinovac's AI vaccine, was completed its preclinica...
AZ Korea celebrating 2nd year of Iressa market launching.
AstraZeneca Korea will have a conference under the subject of "Iressa lung cancer expert symposium" jointly with Korean Cancer Study Group at Emerald room Yongbin Guan, Shilla hotel Seoul on April 15 (Sat).
The sy...
